| Tissue microarrays for rapid linking of molecular changes to clinical endpoints J Torhorst, C Bucher, J Kononen, P Haas, M Zuber, OR Köchli, F Mross, ... The American journal of pathology 159 (6), 2249-2256, 2001 | 770 | 2001 |
| Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis M Bärlund, F Forozan, J Kononen, L Bubendorf, Y Chen, ML Bittner, ... Journal of the National Cancer Institute 92 (15), 1252-1259, 2000 | 410 | 2000 |
| Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer R Simon, A Nocito, T Hübscher, C Bucher, J Torhorst, P Schraml, ... Journal of the National Cancer Institute 93 (15), 1141-1146, 2001 | 364 | 2001 |
| Vstm3 is a member of the CD28 family and an important modulator of T‐cell function SD Levin, DW Taft, CS Brandt, C Bucher, ED Howard, EM Chadwick, ... European journal of immunology 41 (4), 902-915, 2011 | 362 | 2011 |
| Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donor M Stern, L Ruggeri, A Mancusi, ME Bernardo, C de Angelis, C Bucher, ... Blood, The Journal of the American Society of Hematology 112 (7), 2990-2995, 2008 | 276 | 2008 |
| Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease N Cantoni, HH Hirsch, N Khanna, S Gerull, A Buser, C Bucher, J Halter, ... Biology of blood and marrow transplantation 16 (9), 1309-1314, 2010 | 271 | 2010 |
| Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation A Tichelli, C Bucher, A Rovó, G Stussi, M Stern, M Paulussen, J Halter, ... Blood, The Journal of the American Society of Hematology 110 (9), 3463-3471, 2007 | 257 | 2007 |
| Cyclin E overexpression and amplification in human tumours P Schraml, C Bucher, H Bissig, A Nocito, P Haas, K Wilber, S Seelig, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 226 | 2003 |
| Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples A Lugli, Y Forster, P Haas, A Nocito, C Bucher, H Bissig, M Mirlacher, ... Human pathology 34 (10), 994-1000, 2003 | 204 | 2003 |
| Indoleamine 2, 3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality LK Jasperson, C Bucher, A Panoskaltsis-Mortari, PA Taylor, AL Mellor, ... Blood, The Journal of the American Society of Hematology 111 (6), 3257-3265, 2008 | 189 | 2008 |
| Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia Q Zhou, C Bucher, ME Munger, SL Highfill, J Tolar, DH Munn, BL Levine, ... Blood, The Journal of the American Society of Hematology 114 (18), 3793-3802, 2009 | 172 | 2009 |
| IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation C Bucher, L Koch, C Vogtenhuber, E Goren, M Munger, ... Blood, The Journal of the American Society of Hematology 114 (26), 5375-5384, 2009 | 169 | 2009 |
| Inducing the tryptophan catabolic pathway, indoleamine 2, 3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality LK Jasperson, C Bucher, A Panoskaltsis-Mortari, AL Mellor, DH Munn, ... Blood, The Journal of the American Society of Hematology 114 (24), 5062-5070, 2009 | 153 | 2009 |
| The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria A Röth, J Nishimura, Z Nagy, J Gaàl-Weisinger, J Panse, SS Yoon, ... Blood, The Journal of the American Society of Hematology 135 (12), 912-920, 2020 | 106 | 2020 |
| High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays CL Andersen, O Monni, U Wagner, J Kononen, M Bärlund, C Bucher, ... The American journal of pathology 161 (1), 73-79, 2002 | 102 | 2002 |
| Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner JR Passweg, J Halter, C Bucher, S Gerull, D Heim, A Rovó, A Buser, ... Swiss medical weekly 142 (4142), w13696-w13696, 2012 | 91 | 2012 |
| Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes KL Hippen, C Bucher, DK Schirm, AM Bearl, T Brender, KA Mink, ... Blood, The Journal of the American Society of Hematology 119 (2), 619-628, 2012 | 87 | 2012 |
| Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients M Srivastava, L Bubendorf, M Raffeld, C Bucher, J Torhorst, G Sauter, ... Clinical cancer research 10 (7), 2344-2350, 2004 | 75 | 2004 |
| Inactivation of the Adenosine A2A Receptor Protects Apolipoprotein E–Deficient Mice From Atherosclerosis H Wang, W Zhang, C Zhu, C Bucher, BR Blazar, C Zhang, JF Chen, ... Arteriosclerosis, thrombosis, and vascular biology 29 (7), 1046-1052, 2009 | 71 | 2009 |
| Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector … C Vogtenhuber, C Bucher, SL Highfill, LK Koch, E Goren, ... Blood, The Journal of the American Society of Hematology 116 (3), 466-474, 2010 | 63 | 2010 |
